NEW OPHTHALMIC USES FOR EXISTING DRUGS
Chairpersons:
Dr. Peter Kador, Univ. Nebraska Medical Center
Dr. Illés Kovács, Semmelweis University, Hungary
Confirmed speakers include:
Dr. Marjorie Lou, Univ. Nebraska at Lincoln
THIOREDOXIN ACTIVITY AND TBP2 EXPRESSION IN DIABETIC LENSES ARE LINKED TO ALDOSE REDUCTASE ACTIVITY
Dr. Milton Wyman, Therapeutic Vision, Inc
TOPICAL ALDOSE REDUCTASE INHIBITOR KINOSTAT PREVENTS THE CLINICAL DEVELOPMENT OF CATARACT IN DIABETIC DOGS – AN UPDATE
Dr. Peter Kador, Univ. Nebraska Medical Center
TRANSGENIC AK-SMAA-GFPHAR MICE SUPPORT THE PREMISE THAT ALDOSE REDUCTASE INITIATES DIABETIC RETINOPATHY
14 December 2012